178 related articles for article (PubMed ID: 26377996)
1. Loss of interleukin-21 leads to atrophic germinal centers in multicentric Castleman's disease.
Yajima H; Yamamoto M; Shimizu Y; Sakurai N; Suzuki C; Naishiro Y; Imai K; Shinomura Y; Takahashi H
Ann Hematol; 2016 Jan; 95(1):35-40. PubMed ID: 26377996
[TBL] [Abstract][Full Text] [Related]
2. IL-6 expression helps distinguish Castleman's disease from IgG4-related disease in the lung.
Kinugawa Y; Uehara T; Iwaya M; Asaka S; Kobayashi S; Nakajima T; Komatsu M; Yasuo M; Yamamoto H; Ota H
BMC Pulm Med; 2021 Jul; 21(1):219. PubMed ID: 34246246
[TBL] [Abstract][Full Text] [Related]
3. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease.
Sato Y; Kojima M; Takata K; Morito T; Asaoku H; Takeuchi T; Mizobuchi K; Fujihara M; Kuraoka K; Nakai T; Ichimura K; Tanaka T; Tamura M; Nishikawa Y; Yoshino T
Mod Pathol; 2009 Apr; 22(4):589-99. PubMed ID: 19270642
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic multicentric Castleman's disease. A clinicopathologic and immunohistochemical study of five cases.
Kojima M; Nakamura S; Nishikawa M; Itoh H; Miyawaki S; Masawa N
Pathol Res Pract; 2005; 201(4):325-32. PubMed ID: 15991840
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic multicentric castleman's disease mimicking immunoglobulin G4-related disease responding well to Bortezomib: a case report.
Peng Q; Wu F; Shi Y; Wang J; Zhai Z; Wang Z
BMC Nephrol; 2023 Oct; 24(1):290. PubMed ID: 37784011
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin G4-related disease and idiopathic multicentric Castleman's disease: confusable immune-mediated disorders.
Sasaki T; Akiyama M; Kaneko Y; Takeuchi T
Rheumatology (Oxford); 2022 Feb; 61(2):490-501. PubMed ID: 34363463
[TBL] [Abstract][Full Text] [Related]
7. Overlap of IgG4-related Disease and Multicentric Castleman's Disease in a Patient with Skin Lesions.
Mochizuki H; Kato M; Higuchi T; Koyamada R; Arai S; Okada S; Eto H
Intern Med; 2017; 56(9):1095-1099. PubMed ID: 28458319
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
Nishi J; Maruyama I
Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
[TBL] [Abstract][Full Text] [Related]
9. Comparison of IgG4-Related Lymphadenopathy and Multicentric Castleman's Disease: a Retrospective Study.
Sun C; Xu G; Lin J
Clin Lab; 2018 Oct; 64(10):1671-1678. PubMed ID: 30336525
[TBL] [Abstract][Full Text] [Related]
10. "Follicular variant" of hyaline-vascular type of Castleman's disease: histopathological and immunohistochemical study of 11 cases.
Kojima M; Shimizu K; Ikota H; Ohno Y; Motoori T; Itoh H; Masawa N; Nakamura S
J Clin Exp Hematop; 2008 Nov; 48(2):39-45. PubMed ID: 19039195
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease.
Terasaki Y; Ikushima S; Matsui S; Hebisawa A; Ichimura Y; Izumi S; Ujita M; Arita M; Tomii K; Komase Y; Owan I; Kawamura T; Matsuzawa Y; Murakami M; Ishimoto H; Kimura H; Bando M; Nishimoto N; Kawabata Y; Fukuda Y; Ogura T;
Histopathology; 2017 Jun; 70(7):1114-1124. PubMed ID: 28207938
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of a concurrent condition of IgG4-RD and Castleman's disease.
Zhang X; Zhang P; Peng L; Fei Y; Zhang W; Feng R; Zhang W
Clin Rheumatol; 2018 Dec; 37(12):3387-3395. PubMed ID: 29948354
[TBL] [Abstract][Full Text] [Related]
13. Multicentric Castleman's disease associated with inherited epidermolysis bullosa.
Kawakami Y; Nishibu A; Kikuchi S; Ohtsuka M; Nakamura K; Nozawa Y; Abe M; Iwatsuki K; Kaneko F
J Dermatol; 2003 Sep; 30(9):689-93. PubMed ID: 14578560
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies.
Menke DM; Tiemann M; Camoriano JK; Chang SF; Madan A; Chow M; Habermann TM; Parwaresch R
Am J Clin Pathol; 1996 Mar; 105(3):268-76. PubMed ID: 8602606
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.
Yoshizaki K; Matsuda T; Nishimoto N; Kuritani T; Taeho L; Aozasa K; Nakahata T; Kawai H; Tagoh H; Komori T
Blood; 1989 Sep; 74(4):1360-7. PubMed ID: 2788466
[TBL] [Abstract][Full Text] [Related]
16. A case of IgG4-related lung disease associated with multicentric Castleman's disease and lung cancer.
Ikari J; Kojima M; Tomita K; Nakamura T; Toyoda F; Otsuki Y; Shimizu S; Kobayashi H; Nakamura H
Intern Med; 2010; 49(13):1287-91. PubMed ID: 20606361
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease.
Maehara T; Moriyama M; Nakashima H; Miyake K; Hayashida JN; Tanaka A; Shinozaki S; Kubo Y; Nakamura S
Ann Rheum Dis; 2012 Dec; 71(12):2011-19. PubMed ID: 22753386
[TBL] [Abstract][Full Text] [Related]
18. Multicentric Castleman disease mimicking IgG4-related disease: A case report.
Izumi Y; Takeshita H; Moriwaki Y; Hisatomi K; Matsuda M; Yamashita N; Kawahara C; Shigemitsu Y; Iwanaga N; Kawakami A; Kurohama H; Niino D; Ito M; Migita K
Mod Rheumatol; 2017 Jan; 27(1):174-177. PubMed ID: 25528859
[TBL] [Abstract][Full Text] [Related]
19. Mixed-type multicentric Castleman's disease developing during a 17-year follow-up of sarcoidosis.
Awano N; Inomata M; Kondoh K; Satake K; Kamiya H; Moriya A; Ando T; Kumasaka T; Takemura T; Takeuchi K; Ikushima S
Intern Med; 2012; 51(21):3061-6. PubMed ID: 23124151
[TBL] [Abstract][Full Text] [Related]
20. Clinical, laboratory and imaging findings in Castleman's disease - The subtype decides.
Haap M; Wiefels J; Horger M; Hoyer A; Müssig K
Blood Rev; 2018 May; 32(3):225-234. PubMed ID: 29223447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
